The use of the Artificial Intelligence has been increasing in various sectors of Pharmaceutical Industry. AI models are used to determine relationship between the structural properties of chemical compounds and biological toxicity. AI is impacting drug discovery in new and previously unimaginable ways.Investors have largerly gravitated toward the hype throwing an un-precedented amount of funding toward Artificial Intelligence in Drug Discovery. Artificail Intelligence in Drug Discovery not only flash gene-sequencing work,but also trained to predict drug efficacy and side effects. By implementing AI solutions, the length of the clinical trial cycle is shortened, and the procedure is more efficient and accurate. As a result, stakeholders in the life science industry are becoming more and more interested in implementing these cutting-edge AI solutions in drug discovery procedures. The strategic alliances and collaborations between the largest AI-based drug discovery businesses and pharmaceutical corporations expanded from 4 partnerships in 2015 to 27 partnerships in 2020, according to Clinical Trials Arena data forecasts for 2021.
- https://www.maximizemarketresearch.com/market-report/ai-in-drug-discovery-market/161733/
-
The use of the Artificial Intelligence has been increasing in various sectors of Pharmaceutical Industry. AI models are used to determine relationship between the structural properties of chemical compounds and biological toxicity. AI is impacting drug discovery in new and previously unimaginable ways.Investors have largerly gravitated toward the hype throwing an un-precedented amount of funding toward Artificial Intelligence in Drug Discovery. Artificail Intelligence in Drug Discovery not only flash gene-sequencing work,but also trained to predict drug efficacy and side effects. By implementing AI solutions, the length of the clinical trial cycle is shortened, and the procedure is more efficient and accurate. As a result, stakeholders in the life science industry are becoming more and more interested in implementing these cutting-edge AI solutions in drug discovery procedures. The strategic alliances and collaborations between the largest AI-based drug discovery businesses and pharmaceutical corporations expanded from 4 partnerships in 2015 to 27 partnerships in 2020, according to Clinical Trials Arena data forecasts for 2021.
- India